our main products are : ● packaged products for retail sale to consumers for eyeglass and sunglass lens cleaning and conditioning , ● packaged products for retail sale to consumers for anti-fog and conditioning of masks and goggles , ● packaged products for sale to the military for safety anti-fogging and conditioning of lenses , masks , head gear and other applications such as head 's up displays , ● liquids for sale to industrial customers who resell to those who need porcelain coatings for restaurant dinnerware , and ● liquids for sale to suppliers to local governments and agencies for coatings for porcelain and other applications in mass transportation . in addition , we have developed a series of formulations used in the manufacture of precision casting and decorative architectural glass products which provides a barrier to soiling , helping keep decorative art-glass clean longer and making it easier to clean . separate from our historical business , we are also focused on creating products enabled by nanotechnology that tackle and solve big , global problems in growing markets . we have three primary areas of new product focus : 1. health ; 2. safety ; and 3. sustainability . the first new product is expected to be part of a family of cleaning products that clean and fortify surfaces at the nanoscale-level . this fortifier and protector can clean and protect many surfaces , both natural and man-made . after application , the product continues to fortify and protect , creating a healthy surface research and development segment this segment focuses its efforts on research and development of proof of concepts and prototypes for proposed pen products and on performing research and development services to government and private entities . we are developing technologies that generally fall under one of three technology platforms . these platforms are : 20 ● nanosensor technology ; ● nanoelectronics ; and ● submicron particle formulations for health and safety products . our research and development efforts are currently focused in these and emerging areas . recent developments pen is focused on the development of new products using the strong intellectual property portfolio acquired in the combination . the product segment will continue to grow its product sales and develop its product offerings . the research and development segment is working on product prototypes for new product offerings and is also continues to perform research and development for a fee from government and private customers . currently , our research and development segment includes research and development activities of our newly formed subsidiary , pen technology , llc . effective january 26 , 2016 we effected a 180 to 1 reverse split of our outstanding common stock . at the same time we reduced the number of our authorized shares of common stock to a total of 10,000,000 shares comprised of 7,200,000 shares of class a common stock , 2,500,000 shares of class b common stock , and 300,000 shares of class z common stock and set a par value of $ 0.0001 per share of all classes of our common stock upon the effectiveness of the reverse stock split . all share and per share data in this report have been retroactively restated to reflect the effect of the reverse split and authorized shares . results of operations the following comparative analysis on results of operations was based primarily on the comparative consolidated financial statements , footnotes and related information for the periods identified below and should be read in conjunction with the consolidated financial statements and the notes to those statements that are included elsewhere in this report . the results discussed below are for the years ended december 31 , 2015 and 2014. for the 2014 period , substantially all of our results of operations relate to our product segment since the results of operations related to our research and development segment are only included in our results of operations for the period from august 27 , 2014 , ( the effective date of the merger ) to december 31 . 2014. the acquired research and development segment has a history of net losses and negative cash flow from operations . since the combination , we have made efforts to cut costs and have subleased excess space in order to reduce net losses and cash used in operations . we continue to monitor costs and to reduce costs in order to achieve positive or break-even cash flow from operations in this segment . comparison of results of operations for the year ended december 31 , 2015 and 2014 revenues : for the years ended december 31 , 2015 and 2014 , revenues consisted of the following : replace_table_token_2_th for the year ended december 31 , 2015 , sales from the product segment decreased by $ 1,257,420 or 13.7 % as compared to the year ended december 31 , 2014 and was primarily attributable to lower sales of anti-fog products . in 2013 , we experienced delays in the production of anti-fog cloths which resulted in heavier than normal sales in the first half of 2014 . 21 for the year ended december 31 , 2015 , sales from our research and development segment totaled $ 1,764,924. for the year ended december 31 , 2014 , we reported sales of this segment of $ 772,909 representing sales from august 27 , 2014 ( the date of combination ) to december 31 , 2014. cost of revenues . cost of revenues includes inventory costs , materials and supplies costs , internal labor and related benefits , subcontractor costs , depreciation , overhead and shipping and handling costs incurred including research and development costs related to government and private research contracts in our research and development segment . story_separator_special_tag types of revenue : ● net product sales by our subsidiary nanofilm . ● reimbursements under agreements to perform research and development for government agencies and others by our subsidiary , applied nanotech . we do not perform research contracts that are contingent upon successful results . larger projects are sometimes broken down in phases to allow the customer to determine at the end of each phase if they wish to move to the next phase . the agreements with federal government agencies generally provide that , upon completion of a technology development program , the funding agency is granted a royalty-free license to use any technology developed during the course of the program for its own purposes , but not any preexisting technology that we use in connection with the program . we retain all other rights to use , develop , and commercialize the technology . agreements with nongovernmental entities generally allow the entity the first opportunity to license the technology from us upon completion of the project . ● product sales and other miscellaneous revenues from our subsidiary , applied nanotech such as the sale of conductive inks and thermal management materials . 26 revenue recognition criteria : ● net product sales by our subsidiary nano , are recognized when the product is shipped to the customer and title is transferred . ● revenue from research and development government contracts is recognized when it is earned pursuant to the terms of the contract . these projects are usually billed monthly based on costs , hours , or some other measure of activity during the month and revenue is recognized as services are provided . if there is substantive acceptance terms then revenue will not be recognized until acceptance occurs . the recognition of revenue may not correspond with the billings allowable under the contract . to the extent that billings exceed revenue earned , a portion of the revenue is deferred until such time as it is earned . ● revenue from research and development non-governmental contracts is recognized when it is earned pursuant to the terms of the contract . each contract is unique and tailored to the needs of the customer and goals of the project . some contracts may call for a monthly payment for a fixed period of time . other contracts may be for a fixed dollar amount with an unspecified time period , although there is frequently a targeted completion date . these contracts generally involve some sort of up-front payment . some contracts may call for the delivery of samples , or may call for the transfer of equipment or other items developed during the project to the customer . these projects are usually billed monthly based on costs , hours , or some other measure of activity during the month and revenue is recognized as services are provided . if there is substantive acceptance terms then revenue will not be recognized until acceptance occurs . ● revenue from other product sales is recognized at the time the product shipped . the company 's subsidiary applied nanotech 's primary business is research and development and the licensing of its technology , not the sale of products . product sales are generally insignificant in number , and are generally limited to the sale of conductive inks , thermal management materials , samples , proofs of concepts , prototypes , or other items resulting from its research . ● other miscellaneous revenue is recognized as deemed appropriate given the facts of the situation and is generally not material . research and development research and development costs incurred in the development of our products and under other company sponsored research and development projects are expensed as incurred . costs such as direct labor , direct costs , and other allocated costs incurred to perform research and development service pursuant to government and private research projects are included in cost of sales . stock-based compensation stock-based compensation is accounted for based on the requirements of the share-based payment topic of asc 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award ( presumptively , the vesting period ) . the asc also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award . pursuant to asc topic 505-50 , for share-based payments to consultants and other third-parties , compensation expense is determined at the “ measurement date . ” the expense is recognized over the service period of the award . until the measurement date is reached , the total amount of compensation expense remains uncertain . we initially record compensation expense based on the fair value of the award at the reporting date . 27 segment reporting we use “ the management approach ” in determining reportable operating segments . the management approach considers the internal organization and reporting used by our chief operating decision maker for making operating decisions and assessing performance as the source for determining our reportable segments . our chief operating decision maker is the chairman and chief executive officer ( “ ceo ” ) of the company , who reviews operating results to make decisions about allocating resources and assessing performance for the entire company . we classified the reportable operating segments into ( i ) the development , manufacture and sale of personal lens cleaners and accessories and ultra-thin films of organic or polymeric crystals ( the “ product segment ” ) and ( ii ) the performance of nanotechnology research and development services for government and private entities and any related sales of related products ( the “ research and development segment ” ) . recent accounting pronouncements there are no recent accounting pronouncements that we have not

liquidity and capital resources liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements . we had working capital deficit of $ ( 889,657 ) and $ 262,519 of cash as of december 31 , 2015 and working capital of $ 86,636 and $ 464,735 of cash as of december 31 , 2014. the following table sets forth a summary of changes in our working capital from december 31 , 2014 to december 31 , 2015 : replace_table_token_6_th the decrease in working capital was primarily attributable to the decrease in cash of approximately $ 202,000 , a decrease in inventory of $ 474,000 , an increase in the bank revolving line of credit of $ 515,000 and an increase in current portion of notes payable of $ 74,000 offset by an increase in accounts receivable of approximately $ 41,000 , a decrease in accounts payable of approximately $ 140,000 and a decrease in accrued expenses of approximately $ 93,000. net cash flow used in operating activities was $ ( 804,208 ) for the year ended december 31 , 2015 as compared to net cash provided by operating activities of $ 547,647 for the year ended december 31 , 2014 , a decrease of $ 1,351,855 .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```liquidity and capital resources liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements . we had working capital deficit of $ ( 889,657 ) and $ 262,519 of cash as of december 31 , 2015 and working capital of $ 86,636 and $ 464,735 of cash as of december 31 , 2014. the following table sets forth a summary of changes in our working capital from december 31 , 2014 to december 31 , 2015 : replace_table_token_6_th the decrease in working capital was primarily attributable to the decrease in cash of approximately $ 202,000 , a decrease in inventory of $ 474,000 , an increase in the bank revolving line of credit of $ 515,000 and an increase in current portion of notes payable of $ 74,000 offset by an increase in accounts receivable of approximately $ 41,000 , a decrease in accounts payable of approximately $ 140,000 and a decrease in accrued expenses of approximately $ 93,000. net cash flow used in operating activities was $ ( 804,208 ) for the year ended december 31 , 2015 as compared to net cash provided by operating activities of $ 547,647 for the year ended december 31 , 2014 , a decrease of $ 1,351,855 .
```    
 Suspicious Activity Report : our main products are : ● packaged products for retail sale to consumers for eyeglass and sunglass lens cleaning and conditioning , ● packaged products for retail sale to consumers for anti-fog and conditioning of masks and goggles , ● packaged products for sale to the military for safety anti-fogging and conditioning of lenses , masks , head gear and other applications such as head 's up displays , ● liquids for sale to industrial customers who resell to those who need porcelain coatings for restaurant dinnerware , and ● liquids for sale to suppliers to local governments and agencies for coatings for porcelain and other applications in mass transportation . in addition , we have developed a series of formulations used in the manufacture of precision casting and decorative architectural glass products which provides a barrier to soiling , helping keep decorative art-glass clean longer and making it easier to clean . separate from our historical business , we are also focused on creating products enabled by nanotechnology that tackle and solve big , global problems in growing markets . we have three primary areas of new product focus : 1. health ; 2. safety ; and 3. sustainability . the first new product is expected to be part of a family of cleaning products that clean and fortify surfaces at the nanoscale-level . this fortifier and protector can clean and protect many surfaces , both natural and man-made . after application , the product continues to fortify and protect , creating a healthy surface research and development segment this segment focuses its efforts on research and development of proof of concepts and prototypes for proposed pen products and on performing research and development services to government and private entities . we are developing technologies that generally fall under one of three technology platforms . these platforms are : 20 ● nanosensor technology ; ● nanoelectronics ; and ● submicron particle formulations for health and safety products . our research and development efforts are currently focused in these and emerging areas . recent developments pen is focused on the development of new products using the strong intellectual property portfolio acquired in the combination . the product segment will continue to grow its product sales and develop its product offerings . the research and development segment is working on product prototypes for new product offerings and is also continues to perform research and development for a fee from government and private customers . currently , our research and development segment includes research and development activities of our newly formed subsidiary , pen technology , llc . effective january 26 , 2016 we effected a 180 to 1 reverse split of our outstanding common stock . at the same time we reduced the number of our authorized shares of common stock to a total of 10,000,000 shares comprised of 7,200,000 shares of class a common stock , 2,500,000 shares of class b common stock , and 300,000 shares of class z common stock and set a par value of $ 0.0001 per share of all classes of our common stock upon the effectiveness of the reverse stock split . all share and per share data in this report have been retroactively restated to reflect the effect of the reverse split and authorized shares . results of operations the following comparative analysis on results of operations was based primarily on the comparative consolidated financial statements , footnotes and related information for the periods identified below and should be read in conjunction with the consolidated financial statements and the notes to those statements that are included elsewhere in this report . the results discussed below are for the years ended december 31 , 2015 and 2014. for the 2014 period , substantially all of our results of operations relate to our product segment since the results of operations related to our research and development segment are only included in our results of operations for the period from august 27 , 2014 , ( the effective date of the merger ) to december 31 . 2014. the acquired research and development segment has a history of net losses and negative cash flow from operations . since the combination , we have made efforts to cut costs and have subleased excess space in order to reduce net losses and cash used in operations . we continue to monitor costs and to reduce costs in order to achieve positive or break-even cash flow from operations in this segment . comparison of results of operations for the year ended december 31 , 2015 and 2014 revenues : for the years ended december 31 , 2015 and 2014 , revenues consisted of the following : replace_table_token_2_th for the year ended december 31 , 2015 , sales from the product segment decreased by $ 1,257,420 or 13.7 % as compared to the year ended december 31 , 2014 and was primarily attributable to lower sales of anti-fog products . in 2013 , we experienced delays in the production of anti-fog cloths which resulted in heavier than normal sales in the first half of 2014 . 21 for the year ended december 31 , 2015 , sales from our research and development segment totaled $ 1,764,924. for the year ended december 31 , 2014 , we reported sales of this segment of $ 772,909 representing sales from august 27 , 2014 ( the date of combination ) to december 31 , 2014. cost of revenues . cost of revenues includes inventory costs , materials and supplies costs , internal labor and related benefits , subcontractor costs , depreciation , overhead and shipping and handling costs incurred including research and development costs related to government and private research contracts in our research and development segment . story_separator_special_tag types of revenue : ● net product sales by our subsidiary nanofilm . ● reimbursements under agreements to perform research and development for government agencies and others by our subsidiary , applied nanotech . we do not perform research contracts that are contingent upon successful results . larger projects are sometimes broken down in phases to allow the customer to determine at the end of each phase if they wish to move to the next phase . the agreements with federal government agencies generally provide that , upon completion of a technology development program , the funding agency is granted a royalty-free license to use any technology developed during the course of the program for its own purposes , but not any preexisting technology that we use in connection with the program . we retain all other rights to use , develop , and commercialize the technology . agreements with nongovernmental entities generally allow the entity the first opportunity to license the technology from us upon completion of the project . ● product sales and other miscellaneous revenues from our subsidiary , applied nanotech such as the sale of conductive inks and thermal management materials . 26 revenue recognition criteria : ● net product sales by our subsidiary nano , are recognized when the product is shipped to the customer and title is transferred . ● revenue from research and development government contracts is recognized when it is earned pursuant to the terms of the contract . these projects are usually billed monthly based on costs , hours , or some other measure of activity during the month and revenue is recognized as services are provided . if there is substantive acceptance terms then revenue will not be recognized until acceptance occurs . the recognition of revenue may not correspond with the billings allowable under the contract . to the extent that billings exceed revenue earned , a portion of the revenue is deferred until such time as it is earned . ● revenue from research and development non-governmental contracts is recognized when it is earned pursuant to the terms of the contract . each contract is unique and tailored to the needs of the customer and goals of the project . some contracts may call for a monthly payment for a fixed period of time . other contracts may be for a fixed dollar amount with an unspecified time period , although there is frequently a targeted completion date . these contracts generally involve some sort of up-front payment . some contracts may call for the delivery of samples , or may call for the transfer of equipment or other items developed during the project to the customer . these projects are usually billed monthly based on costs , hours , or some other measure of activity during the month and revenue is recognized as services are provided . if there is substantive acceptance terms then revenue will not be recognized until acceptance occurs . ● revenue from other product sales is recognized at the time the product shipped . the company 's subsidiary applied nanotech 's primary business is research and development and the licensing of its technology , not the sale of products . product sales are generally insignificant in number , and are generally limited to the sale of conductive inks , thermal management materials , samples , proofs of concepts , prototypes , or other items resulting from its research . ● other miscellaneous revenue is recognized as deemed appropriate given the facts of the situation and is generally not material . research and development research and development costs incurred in the development of our products and under other company sponsored research and development projects are expensed as incurred . costs such as direct labor , direct costs , and other allocated costs incurred to perform research and development service pursuant to government and private research projects are included in cost of sales . stock-based compensation stock-based compensation is accounted for based on the requirements of the share-based payment topic of asc 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award ( presumptively , the vesting period ) . the asc also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award . pursuant to asc topic 505-50 , for share-based payments to consultants and other third-parties , compensation expense is determined at the “ measurement date . ” the expense is recognized over the service period of the award . until the measurement date is reached , the total amount of compensation expense remains uncertain . we initially record compensation expense based on the fair value of the award at the reporting date . 27 segment reporting we use “ the management approach ” in determining reportable operating segments . the management approach considers the internal organization and reporting used by our chief operating decision maker for making operating decisions and assessing performance as the source for determining our reportable segments . our chief operating decision maker is the chairman and chief executive officer ( “ ceo ” ) of the company , who reviews operating results to make decisions about allocating resources and assessing performance for the entire company . we classified the reportable operating segments into ( i ) the development , manufacture and sale of personal lens cleaners and accessories and ultra-thin films of organic or polymeric crystals ( the “ product segment ” ) and ( ii ) the performance of nanotechnology research and development services for government and private entities and any related sales of related products ( the “ research and development segment ” ) . recent accounting pronouncements there are no recent accounting pronouncements that we have not

